(Q38312218)

English

Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer

scientific article published on May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer (English)

1 reference

Europe PubMed Central

2 September 2017

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

Nicola Doldi

1

1 reference

Europe PubMed Central

2 September 2017

Paola Persico

2

1 reference

Europe PubMed Central

2 September 2017

Francesca Di Sebastiano

3

1 reference

Europe PubMed Central

2 September 2017

Elena Marsiglio

4

1 reference

Europe PubMed Central

2 September 2017

Augusto Ferrari

5

1 reference

Europe PubMed Central

2 September 2017

publication date

1 May 2006

1 reference

Europe PubMed Central

2 September 2017

Gynecological Endocrinology

1 reference

Europe PubMed Central

2 September 2017

22

1 reference

Europe PubMed Central

2 September 2017

5

1 reference

Europe PubMed Central

2 September 2017

235-238

1 reference

Europe PubMed Central

2 September 2017

Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

The management of infertility associated with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

Concurrent ganirelix and follitropin beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy

1 reference

https://api.crossref.org/works/10.1080%2F14767050600761893

21 January 2018

Identifiers

10.1080/14767050600761893

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38312218&oldid=1753009221"